Revision history of "Development of an innovative formulation of a monoclonal antibody for use in the treatment of non-specific bowel inflammatory conditions" (Q78333)

12 October 2024

• curprev 21:4021:40, 12 October 2024‎ DG Regio talk contribs‎ 77,996 bytes −11‎ ‎Changed label, description and/or aliases in pt
• curprev 21:4021:40, 12 October 2024‎ DG Regio talk contribs‎ 78,007 bytes −40‎ ‎Set a claim value: summary (P836): Os anticorpos monoclonais são agora comumente utilizados para tratar doenças para as quais não existia uma farmacoterapia eficaz há vários anos. No caso da esclerose múltipla, artrite reumatóide ou psoríase, a terapia com anticorpos monoclonais dá resultados mais do que satisfatórios. Contudo, exigem despesas financeiras elevadas – dependendo da condição, o custo da terapia pode atingir várias centenas de milhares de zlótis por ano por pacient...

7 March 2024

• curprev 13:5513:55, 7 March 2024‎ DG Regio talk contribs‎ 78,047 bytes +288‎ ‎Added qualifier: readability score (P590521): 0.4557294526558177

12 January 2024

• curprev 16:1516:15, 12 January 2024‎ DG Regio talk contribs‎ 77,759 bytes +1,083‎ ‎Changed an Item

11 June 2023

• curprev 11:0911:09, 11 June 2023‎ Admin talk contribs‎ 76,676 bytes +435‎ BatchIngestion

24 May 2023

• curprev 16:5916:59, 24 May 2023‎ DG Regio talk contribs‎ 76,241 bytes +949‎ ‎Changed an Item

2 March 2023

• curprev 22:2222:22, 2 March 2023‎ DG Regio talk contribs‎ 75,292 bytes +1,519‎ ‎Changed label, description and/or aliases in it, da, bg, sk, lv, el, fr, ro, et, sl, pt, ga, fi, cs, sv, de, es, hr, hu, lt, nl, mt, and other parts

25 October 2022

• curprev 11:5811:58, 25 October 2022‎ DG Regio talk contribs‎ 73,773 bytes +848‎ ‎Changed an Item: Import item from Poland

20 October 2022

• curprev 00:0800:08, 20 October 2022‎ DG Regio talk contribs‎ 72,925 bytes +1,227‎ ‎Changed an Item: Import item from Poland
• curprev 00:0800:08, 20 October 2022‎ DG Regio talk contribs‎ 71,698 bytes −419‎ ‎Removed claim: co-financing rate (P837): 53.66 percentage

25 July 2022

• curprev 20:3220:32, 25 July 2022‎ DG Regio talk contribs‎ 72,117 bytes +45,327‎ ‎Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et,

19 January 2022

• curprev 11:1511:15, 19 January 2022‎ DG Regio talk contribs‎ 26,790 bytes +2,588‎ ‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations

15 January 2022

• curprev 22:2922:29, 15 January 2022‎ DG Regio talk contribs‎ 24,202 bytes +2,481‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

16 December 2021

• curprev 19:3219:32, 16 December 2021‎ DG Regio talk contribs‎ 21,721 bytes +2,557‎ ‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations

7 December 2021

• curprev 08:4108:41, 7 December 2021‎ DG Regio talk contribs‎ 19,164 bytes +2,502‎ ‎Changed label, description and/or aliases in de, and other parts: Adding German translations

30 November 2021

• curprev 15:0115:01, 30 November 2021‎ DG Regio talk contribs‎ 16,662 bytes +2,447‎ ‎Created claim: summary (P836): Les anticorps monoclonaux sont maintenant couramment utilisés pour traiter des affections pour lesquelles aucune pharmacothérapie efficace n’était disponible jusqu’à il y a plusieurs années. Dans le cas de la sclérose en plaques, de la polyarthrite rhumatoïde ou du psoriasis, les traitements d’anticorps monoclonaux donnent des résultats plus que satisfaisants. Cependant, ils nécessitent des dépenses financières élevées – selon l’état, le c...
• curprev 15:0115:01, 30 November 2021‎ DG Regio talk contribs‎ 14,215 bytes +197‎ ‎Changed label, description and/or aliases in fr: translated_label

29 October 2020

• curprev 05:0305:03, 29 October 2020‎ DG Regio talk contribs‎ 14,018 bytes −406‎ ‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement
• curprev 05:0305:03, 29 October 2020‎ DG Regio talk contribs‎ 14,424 bytes −34‎ ‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair

14 October 2020

• curprev 12:0412:04, 14 October 2020‎ DG Regio talk contribs‎ 14,458 bytes +196‎ ‎Changed label, description and/or aliases in 1 language: translated_label
• curprev 12:0412:04, 14 October 2020‎ DG Regio talk contribs‎ 14,262 bytes −192‎ ‎Changed label, description and/or aliases in 1 language: remove_english_label
• curprev 12:0412:04, 14 October 2020‎ DG Regio talk contribs‎ 14,454 bytes +2,127‎ ‎Created claim: summary (P836): Monoclonal antibodies are now commonly used to treat diseases for which no effective pharmacotherapy was available several years ago. In the case of multiple sclerosis, rheumatoid arthritis or psoriasis, monoclonal antibody therapy gives more than satisfactory results. However, they require high financial outlays – depending on the condition, the cost of therapy can reach several hundred thousand zlotys per year per patient. Monoclonal ant...
• curprev 12:0412:04, 14 October 2020‎ DG Regio talk contribs‎ 12,327 bytes −1,774‎ ‎Removed claim: summary (P836): The monoclonal antibodies are now widely used in the treatment of medical conditions, which has not yet been available for several years ago.In the case of multiple sclerosis, rheumatoid arthritis or psoriasis, therapies using monoclonal antibodies give more than satisfactory results.However, they are bound to bear high financial resources & ll;depending on the condition, the cost of the treatment may amount to several hundred thousand zloty p...

25 September 2020

• curprev 00:0600:06, 25 September 2020‎ DG Regio talk contribs‎ 14,101 bytes +1,161‎ ‎Changed an Item: Fixing rounding issue
• curprev 00:0600:06, 25 September 2020‎ DG Regio talk contribs‎ 12,940 bytes −1,162‎ ‎Removed claim: budget (P474): 25,874,319.528 euro

23 September 2020

• curprev 04:2304:23, 23 September 2020‎ DG Regio talk contribs‎ 14,102 bytes +1,161‎ ‎Changed an Item: Fixing rounding issue
• curprev 04:2304:23, 23 September 2020‎ DG Regio talk contribs‎ 12,941 bytes −1,163‎ ‎Removed claim: EU contribution (P835): 13,883,318.4936 euro

15 July 2020

• curprev 18:4118:41, 15 July 2020‎ DG Regio talk contribs‎ 14,104 bytes +431‎ ‎Changed an Item

9 June 2020

• curprev 15:3215:32, 9 June 2020‎ DG Regio talk contribs‎ 13,673 bytes +429‎ ‎Changed an Item

6 June 2020

• curprev 21:3921:39, 6 June 2020‎ DG Regio talk contribs‎ 13,244 bytes +431‎ ‎Changed an Item

26 March 2020

• curprev 10:3310:33, 26 March 2020‎ DG Regio talk contribs‎ 12,813 bytes +431‎ ‎Changed an Item

4 March 2020

• curprev 09:1209:12, 4 March 2020‎ DG Regio talk contribs‎ 12,382 bytes +1,774‎ ‎Created claim: summary (P836): The monoclonal antibodies are now widely used in the treatment of medical conditions, which has not yet been available for several years ago.In the case of multiple sclerosis, rheumatoid arthritis or psoriasis, therapies using monoclonal antibodies give more than satisfactory results.However, they are bound to bear high financial resources & ll;depending on the condition, the cost of the treatment may amount to several hundred thousand zloty per...

18 February 2020

• curprev 07:0907:09, 18 February 2020‎ DG Regio talk contribs‎ 10,608 bytes +192‎ ‎Changed an Item: Label in wikidata changed

8 February 2020

• curprev 16:0016:00, 8 February 2020‎ DG Regio talk contribs‎ 10,416 bytes +823‎ ‎Changed an Item
• curprev 16:0016:00, 8 February 2020‎ DG Regio talk contribs‎ 9,593 bytes −417‎ ‎Removed claim: financed by (P890): European Union (Q1)

31 January 2020

• curprev 16:0816:08, 31 January 2020‎ DG Regio talk contribs‎ 10,010 bytes +1,348‎ ‎Changed an Item
• curprev 16:0816:08, 31 January 2020‎ DG Regio talk contribs‎ 8,662 bytes −844‎ ‎Removed claims
• curprev 09:5209:52, 31 January 2020‎ DG Regio talk contribs‎ 9,506 bytes +844‎ ‎Changed an Item

13 January 2020

• curprev 21:0421:04, 13 January 2020‎ DG Regio talk contribs‎ 8,662 bytes +8,662‎ ‎Created a new Item